ATE113596T1 - Pyrrolo(1,4>benzodiazepinderivate. - Google Patents

Pyrrolo(1,4>benzodiazepinderivate.

Info

Publication number
ATE113596T1
ATE113596T1 AT89114483T AT89114483T ATE113596T1 AT E113596 T1 ATE113596 T1 AT E113596T1 AT 89114483 T AT89114483 T AT 89114483T AT 89114483 T AT89114483 T AT 89114483T AT E113596 T1 ATE113596 T1 AT E113596T1
Authority
AT
Austria
Prior art keywords
pyrrolo
benzodiazepin
derivatives
benzodiazepin derivatives
chem
Prior art date
Application number
AT89114483T
Other languages
English (en)
Inventor
Hiromu Matsumura
Hiroshi Hashizume
Akira Matsushita
Masami Eigyo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE113596T1 publication Critical patent/ATE113596T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89114483T 1988-08-05 1989-08-04 Pyrrolo(1,4>benzodiazepinderivate. ATE113596T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63196354A JP2660201B2 (ja) 1988-08-05 1988-08-05 新規ピロロ[1,4]ベンゾジアゼピン誘導体および老人性痴呆薬

Publications (1)

Publication Number Publication Date
ATE113596T1 true ATE113596T1 (de) 1994-11-15

Family

ID=16356444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89114483T ATE113596T1 (de) 1988-08-05 1989-08-04 Pyrrolo(1,4>benzodiazepinderivate.

Country Status (6)

Country Link
US (1) US4923984A (de)
EP (1) EP0353778B1 (de)
JP (1) JP2660201B2 (de)
AT (1) ATE113596T1 (de)
DE (1) DE68919148T2 (de)
ES (1) ES2065954T3 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2795349C (en) 2010-04-15 2016-11-29 Seattle Genetics, Inc. Targeted pyrrolobenzodiazepine conjugates
JP5875083B2 (ja) 2010-04-15 2016-03-02 メディミューン リミテッド 増殖性疾患治療用ピロロベンゾジアゼピン
SG11201400770SA (en) 2011-09-20 2014-04-28 Spirogen Sarl Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
CA2850373C (en) 2011-10-14 2019-07-16 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
AU2012322932B2 (en) 2011-10-14 2016-11-10 Medimmune Limited Pyrrolobenzodiazepines
CN103997893B (zh) 2011-10-14 2019-04-12 西雅图基因公司 吡咯并苯并二氮杂卓和靶向结合物
EP2751111B1 (de) 2011-10-14 2017-04-26 MedImmune Limited Asymmetrische Bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-on) Derivate zur Behandlung von proliferativen oder Autoimmunerkrankungen
ES2680153T3 (es) 2012-10-12 2018-09-04 Adc Therapeutics Sa Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
EP2906249B1 (de) 2012-10-12 2018-06-27 MedImmune Limited Synthese und zwischenprodukte pyrrolobenzodiazepinderivaten zur konjugation
EP2906296B1 (de) 2012-10-12 2018-03-21 ADC Therapeutics SA Pyrrolobenzodiazepin-antikörper-konjugate
RS57694B1 (sr) 2012-10-12 2018-11-30 Adc Therapeutics Sa Pirolobenzodiazepin - anti-psma konjugati antitela
MX338711B (es) 2012-10-12 2016-04-28 Medimmune Ltd Pirrolobenzodiazepinas y conjugados de las mismas.
EP2906297B1 (de) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepin-antikörper-konjugate
HRP20182129T1 (hr) 2012-10-12 2019-02-08 Adc Therapeutics Sa Konjugati protutijelo - pirolobenzodiazepin
HRP20190366T1 (hr) 2012-10-12 2019-04-19 Medimmune Limited Pirolobenzodiazepini i njihovi konjugati
JP6392765B2 (ja) 2012-10-12 2018-09-19 エイディーシー・セラピューティクス・エス・アーAdc Therapeutics Sa ピロロベンゾジアゼピン−抗体結合体
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
EP3054983B1 (de) 2013-10-11 2019-03-20 Medimmune Limited Pyrrolobenzodiazepin-antikörper-konjugate
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
RS61795B1 (sr) 2017-02-08 2021-06-30 Adc Therapeutics Sa Konjugati pirolobenzodiazepin antitela
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
CN110582505B (zh) 2017-04-18 2021-04-02 免疫医疗有限公司 吡咯并苯并二氮杂*缀合物
WO2018193102A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
CA3064804A1 (en) 2017-06-14 2018-12-20 Adc Therapeutics Sa Dosage regimes for the administration of an anti-cd19 adc
KR102270107B1 (ko) 2017-08-18 2021-06-30 메디뮨 리미티드 피롤로벤조디아제핀 컨쥬게이트
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN113631560B (zh) 2019-03-15 2025-02-18 麦迪穆有限责任公司 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物
CN114763356B (zh) * 2021-01-11 2023-06-20 沈阳药科大学 吡咯并苯并二氮杂䓬类化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US3506647A (en) * 1967-04-14 1970-04-14 Sandoz Ag Isoindolo(2,1-d)(1,4)benzodiazepin-6,9(7h,13bh)diones
JPS4925277A (de) * 1972-07-01 1974-03-06
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
US4369138A (en) * 1980-07-15 1983-01-18 Immuno Nuclear Corporation Parathyroid radioimmunoassay

Also Published As

Publication number Publication date
JP2660201B2 (ja) 1997-10-08
DE68919148T2 (de) 1995-03-09
EP0353778A2 (de) 1990-02-07
JPH0245487A (ja) 1990-02-15
US4923984A (en) 1990-05-08
ES2065954T3 (es) 1995-03-01
DE68919148D1 (de) 1994-12-08
EP0353778A3 (de) 1991-07-17
EP0353778B1 (de) 1994-11-02

Similar Documents

Publication Publication Date Title
ATE113596T1 (de) Pyrrolo(1,4>benzodiazepinderivate.
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
DE69115379D1 (de) Neue arylethenylenderivate und verfahren zu ihrer herstellung
HUT49860A (en) Process for producing benzamide-type protease inhibitors
ATE123778T1 (de) Beta-lactam-derivate.
HUT42092A (en) Process for production of derivatives of 3-vinil and 3-ethinil-beta-carbolin and medical preparatives containing thereof
HUT42094A (en) Process for producing new 3-oxadiazol- and 3-carboxylic acid-beta-carbolin derivatives and pharmaceutical compositions containing them
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
HUT59666A (en) Process for producing 2-aryl-5-/trifluoro-methyl/-pyrrole derivatives
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet
EP0597429A3 (de) Verfahren zur Herstellung von 3-Vinylcephalosporinen.
DK0468445T3 (da) Fremgangsmåde til fremstilling af 6-(substitueret aminopropionyl)-derivater af forskolin
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
DK656889A (da) Azabicykliske derivater
ES2157952T3 (es) Preparacion de derivados de beta-lactama e intermediarios.
ATE90101T1 (de) Verfahren zur herstellung von makrolid-derivaten.
TH13494A (th) ไซโคลพรอพิลอะมิโน -1,3,5- ไตรเอซีนแบบถูกแทนที่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee